Elvitegravir/cobicistat/emtricitabine/tenofovir
Elvitegravir/cobicistat/emtricitabine/tenofovir is a medication used for the treatment of HIV/AIDS. It is a combination of four antiretroviral drugs in one pill, taken once a day. The four drugs are elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil.
Composition[edit | edit source]
The medication is composed of four active ingredients:
- Elvitegravir is an integrase inhibitor that prevents the virus from integrating its genetic material into the host cell.
- Cobicistat is a pharmacokinetic enhancer that increases the effectiveness of elvitegravir by inhibiting its metabolism in the liver.
- Emtricitabine and tenofovir disoproxil are nucleoside reverse transcriptase inhibitors (NRTIs) that block a critical step in the replication of the virus.
Indications[edit | edit source]
Elvitegravir/cobicistat/emtricitabine/tenofovir is indicated for the treatment of HIV-1 infection in adults and pediatric patients 12 years of age and older.
Side Effects[edit | edit source]
Common side effects include nausea, diarrhea, and headache. Serious side effects may include liver problems, lactic acidosis, and worsening of hepatitis B in those already infected.
Interactions[edit | edit source]
This medication can interact with other drugs, including other antiretroviral drugs, antacids, and certain cholesterol-lowering drugs.
Pharmacology[edit | edit source]
The combination of these four drugs works synergistically to inhibit the replication of the HIV virus. Elvitegravir inhibits the integrase enzyme, preventing the virus from integrating its genetic material into the host cell. Cobicistat enhances the effectiveness of elvitegravir by inhibiting its metabolism in the liver. Emtricitabine and tenofovir disoproxil are NRTIs that block a critical step in the replication of the virus.
History[edit | edit source]
Elvitegravir/cobicistat/emtricitabine/tenofovir was approved for medical use in the United States in 2012.
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
